+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cannabidiol"

Sturge-Weber Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sturge-Weber Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
German Cannabis Vape Market Overview - Product Thumbnail Image

German Cannabis Vape Market Overview

  • Report
  • November 2019
  • 41 Pages
  • Germany
Seizures Pipeline Insight Analysis Report - Product Thumbnail Image

Seizures Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
From
Autism Pipeline Analysis Report 2025 - Product Thumbnail Image

Autism Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
Tuberous Sclerosis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Tuberous Sclerosis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Seizures Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Seizures Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Cannabidiol (CBD) Market 2025-2029 - Product Thumbnail Image

Cannabidiol (CBD) Market 2025-2029

  • Report
  • April 2025
  • 211 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease. CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions. The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more